Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New approaches to modify glomerular inflammation.

D C Kluth1, A J Rees

  • 1Department of Medicine and Therapeutics, University of Aberdeen, UK.

Journal of Nephrology
|June 23, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adhesion of Escherichia coli under flow conditions reveals potential novel effects of FimH mutations.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2016
Same author

2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides.

Arthritis and rheumatism·2012
Same author

Accurate method for the measurement of small wedge angles.

Applied optics·2010
Same author

Depletion of cells of monocyte lineage prevents loss of renal microvasculature in murine kidney transplantation.

Transplantation·2008
Same author

Pro-resolution properties of macrophages in renal injury.

Kidney international·2007
Same author

A glass foreign body in the knee joint mistaken for ACL avulsion: an unusual case.

Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA·2006
Same journal

Correction to: Abdominal arterial calcification profile in kidney transplant candidates: a comparison between patients with autosomal dominant polycystic kidney disease and those with other causes of kidney failure.

Journal of nephrology·2026
Same journal

Lessons for the Clinical Nephrologist. Not to see the forest for the trees: the diagnostic challenge with valproic acid-induced Fanconi-like proximal tubulopathy.

Journal of nephrology·2026
Same journal

Longitudinal trajectories in multidomain frailty among patients with chronic kidney disease.

Journal of nephrology·2026
Same journal

Correction to: Association between primary care physician-nephrologist collaboration and clinical outcomes in patients with stage 5 chronic kidney disease: a JOINT-KD cohort study.

Journal of nephrology·2026
Same journal

Improving eGFR estimation in diabetic populations: insights from real-world data.

Journal of nephrology·2026
Same journal

Barriers delaying treatment in cases at risk of crush syndrome in major disasters: Kahramanmaraş earthquake experience.

Journal of nephrology·2026
See all related articles

Targeting specific molecular pathways offers new hope for treating glomerulonephritis, a leading cause of kidney failure. Research in animal models shows potential for gene transfer therapies to deliver anti-inflammatory factors, improving treatment prospects.

Area of Science:

  • Nephrology
  • Immunology
  • Molecular Medicine

Background:

  • Glomerulonephritis is a primary cause of end-stage renal failure.
  • Current treatments are non-specific and have significant side effects.
  • Understanding inflammation's cellular and molecular basis is advancing.

Purpose of the Study:

  • To explore potential molecular interventions for glomerulonephritis.
  • To investigate the role of anti-inflammatory cytokines and molecular antagonists.
  • To assess the feasibility of gene transfer for localized anti-inflammatory therapy.

Main Methods:

  • Review of animal models of nephritis.
  • Analysis of molecular targets for inhibiting inflammatory cell migration (chemokines, adhesion molecules).

Related Experiment Videos

  • Evaluation of cytokine antagonists (e.g., IL-1ra, soluble TNF receptors) and anti-inflammatory cytokines (e.g., IL-4, IL-10, TGF-beta) in modulating macrophage activity.

    • Main Results:

    • Specific molecular interventions show promise in animal models.
    • Inhibiting inflammatory cell migration and decreasing pro-inflammatory cytokine activity are viable strategies.
    • Anti-inflammatory cytokines can alter macrophage behavior to favor disease resolution.

    Conclusions:

    • Targeted molecular therapies hold potential for treating glomerulonephritis.
    • Gene transfer technology may enable localized delivery of anti-inflammatory factors.
    • Advancing understanding of inflammation control brings novel therapies closer to clinical application.